Gene · 337
Papers3,283
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,381 to 1,400 of 3,283
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decreased apolipoprotein A4 and increased complement component 3 as potential markers for papillary thyroid carcinoma: A proteomic study. | Int J Biol Markers | 2018 | 30058426 | PubTator, text mining | PubMed |
| New insights into apolipoprotein A5 in controlling lipoprotein metabolism in obesity and the metabolic syndrome patients. | Lipids Health Dis | 2018 | 30053818 | PubTator, text mining | PubMed |
| Quantitative temporal analysis of protein dynamics in cardiac remodeling. | J Mol Cell Cardiol | 2018 | 30009778 | PubTator, text mining | PubMed |
| Expression analysis of apolipoproteins AI & AIV in hepatocellular carcinoma: A protein-based hepatocellular carcinoma-associated study. | Indian J Med Res | 2018 | 29998871 | PubTator, text mining | PubMed |
| Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in Humans. | Circ Genom Precis Med | 2018 | 29987113 | PubTator, text mining | PubMed |
| Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. | Cardiovasc Diabetol | 2018 | 29960584 | PubTator, text mining | PubMed |
| Screening and identification of potential protein biomarkers for evaluating the efficacy of intensive therapy in pulmonary tuberculosis. | Biochem Biophys Res Commun | 2018 | 29959917 | PubTator, text mining | PubMed |
| Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy. | BMC Ophthalmol | 2018 | 29940965 | PubTator, text mining | PubMed |
| Antibiotic-induced changes in the microbiota disrupt redox dynamics in the gut. | Elife | 2018 | 29916366 | PubTator, text mining | PubMed |
| Reconstituted high-density lipoproteins: novel biomimetic nanocarriers for drug delivery. | Acta Pharm Sin B | 2018 | 29872622 | PubTator, text mining | PubMed |
| Prediction of Molecular Mechanisms for LianXia NingXin Formula: A Network Pharmacology Study. | Front Physiol | 2018 | 29867541 | PubTator, text mining | PubMed |
| Signal-Targeted Therapies and Resistance Mechanisms in Pancreatic Cancer: Future Developments Reside in Proteomics. | Cancers (Basel) | 2018 | 29865155 | PubTator, text mining | PubMed |
| Evolution of proteomic biomarker for chronic liver disease: Promise into reality. | J Circ Biomark | 2018 | 29854010 | PubTator, text mining | PubMed |
| Various stress stimuli rewire the profile of liver secretome in a p53-dependent manner. | Cell Death Dis | 2018 | 29844359 | PubTator, text mining | PubMed |
| Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells. | Philos Trans R Soc Lond B Biol Sci | 2018 | 29786565 | PubTator, text mining | PubMed |
| Accelerated pre-senile systemic amyloidosis in PACAP knockout mice - a protective role of PACAP in age-related degenerative processes. | J Pathol | 2018 | 29774542 | PubTator, text mining | PubMed |
Comprehensive proteome analysis of nasal lavage samples after controlled exposure to welding nanoparticles shows an induced acute phase and a nuclear receptor, LXR/RXR, activation that influence the status of the extracellular matrix. | Clin Proteomics | 2018 | 29760600 | PubTator, text mining | PubMed |
| C1q-Mediated Complement Activation and C3 Opsonization Trigger Recognition of Stealth Poly(2-methyl-2-oxazoline)-Coated Silica Nanoparticles by Human Phagocytes. | ACS Nano | 2018 | 29750504 | PubTator, text mining | PubMed |
| Screening of Serum Protein Markers for Avascular Osteonecrosis of Femoral Head Differentially Expressed after Treatment with Yuanshi Shengmai Chenggu Tablets. | Biomed Res Int | 2018 | 29750162 | PubTator, text mining | PubMed |
| Biopharmaceutical insights of particulate emulsified systems - a prospective overview. | Lipids Health Dis | 2018 | 29747645 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/337/papers?page=70